BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$5.32 USD
-0.02 (-0.37%)
Updated May 10, 2024 04:00 PM ET
After-Market: $5.42 +0.10 (1.88%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.19 | 0.00% |
Earnings Summary
For their last quarter, BioCryst Pharmaceuticals (BCRX) reported earnings of -$0.17 per share, beating the Zacks Consensus Estimate of $-0.23 per share. This reflects a positive earnings surprise of 26.09%. Look out for BCRX's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 20.83%.
Earnings History
Price & Consensus
Zacks News for BCRX
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates
BCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services